Publicacións (42) Publicacións de Carmen Conde Muro

2024

  1. Corrigendum: Assessment of mesenchymal stem/stromal cell-based therapy in K/BxN serum transfer-induced arthritis (Frontiers in Immunology, (2022), 13, (943293), 10.3389/fimmu.2022.943293)

    Frontiers in Immunology

2023

  1. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

    Arthritis Research and Therapy, Vol. 25, Núm. 1

  2. HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients

    Rheumatology (United Kingdom), Vol. 62, Núm. 7, pp. 2621-2630

2022

  1. Assessment of mesenchymal stem/stromal cell-based therapy in K/BxN serum transfer-induced arthritis

    Frontiers in Immunology, Vol. 13

  2. Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 74, Núm. 6, pp. 972-983

  3. ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis

    Frontiers in Immunology, Vol. 13

  4. Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy

    Annals of the rheumatic diseases, Vol. 81, Núm. 1, pp. 56-67

2021

  1. Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies

    Scientific Reports, Vol. 11, Núm. 1

  2. Mechanism of Immunoregulatory Properties of Vasoactive Intestinal Peptide in the K/BxN Mice Model of Autoimmune Arthritis

    Frontiers in Immunology, Vol. 12

2020

  1. A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis

    Scientific Reports, Vol. 10, Núm. 1

  2. All-trans retinoic acid inhibits migration and invasiveness of rheumatoid fibroblast-like synoviocytes

    Journal of Pharmacology and Experimental Therapeutics, Vol. 372, Núm. 2, pp. 185-192

  3. Non-Canonical WNT5A Signaling Through RYK Contributes to Aggressive Phenotype of the Rheumatoid Fibroblast-Like Synoviocytes

    Frontiers in Immunology, Vol. 11

  4. Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients

    Rheumatology (United Kingdom), Vol. 59, Núm. 2, pp. 426-438

  5. Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis (Scientific Reports, (2020), 10, 1, (3355), 10.1038/s41598-020-60305-x)

    Scientific Reports

2018

  1. Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis

    Pharmacogenomics Journal, Vol. 18, Núm. 4, pp. 539-545

  2. Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis

    Scientific Reports, Vol. 8, Núm. 1

  3. Uncovering Cellular retinoic acid-binding protein 2 as a potential target for rheumatoid arthritis synovial hyperplasia

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice

    Journal of Bone and Mineral Metabolism, Vol. 33, Núm. 4, pp. 383-391

  2. The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis

    Mediators of Inflammation, Vol. 2015

  3. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis

    European Journal of Pharmacology, Vol. 765, pp. 228-233